Ionis Pharmaceuticals, Inc. (LON:0JDI)
61.11
-2.61 (-4.09%)
At close: Sep 15, 2025
Ionis Pharmaceuticals Market Cap
Ionis Pharmaceuticals has a market cap or net worth of 7.16 billion as of September 16, 2025. Its market cap has increased by 31.45% in one year.
Market Cap
7.16B
Enterprise Value
6.93B
Revenue
689.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
61.11
Market Cap Chart
Since May 17, 1991, Ionis Pharmaceuticals's market cap has increased from 61.76M to 7.16B, an increase of 11,495.74%. That is a compound annual growth rate of 14.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 7.16B | 62.41% |
Dec 31, 2024 | 4.41B | -22.62% |
Dec 29, 2023 | 5.70B | 27.97% |
Dec 30, 2022 | 4.45B | 40.32% |
Dec 31, 2021 | 3.17B | -45.19% |
Dec 31, 2020 | 5.79B | -9.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 182.89B |
GSK plc | 60.53B |
Haleon | 32.39B |
Smith & Nephew | 12.20B |
ConvaTec Group | 4.78B |
Hikma Pharmaceuticals | 3.61B |
HUTCHMED (China) | 2.23B |
Genus | 1.72B |